These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1706817)

  • 1. [FK-506. A new immunosuppressive drug].
    MacLeod AM; Thomson AW
    Medicina (Firenze); 1990; 10(3):329-32. PubMed ID: 1706817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus.
    Spolidorio LC; Spolidorio DM; Massucato EM; Neppelenbroek KH; Campanha NH; Sanches MH
    Oral Dis; 2006 May; 12(3):309-14. PubMed ID: 16700742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
    Lü L; Zhang W; Sun X
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK 506: an immunosuppressant for the 1990s?
    Macleod AM; Thomson AW
    Lancet; 1991 Jan; 337(8732):25-7. PubMed ID: 1702172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK-506--how much potential?
    Thomson AW
    Immunol Today; 1989 Jan; 10(1):6-9. PubMed ID: 2473767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-lymphoid cancer after liver transplantation.
    Frezza EE; Fung JJ; van Thiel DH
    Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
    Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506.
    Krentz AJ; Cramb R; Dousset B; Mayer D; McMaster P; Buckels J; Smith JM; Nattrass M
    J Lab Clin Med; 1994 Sep; 124(3):381-5. PubMed ID: 7521895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
    Lai WJ; Chiang YJ; Chen Y; Chu SH
    Transplant Proc; 2004 Sep; 36(7):2056-7. PubMed ID: 15518744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective immunosuppression with monoclonal antibodies against ICAM-1 and LFA-1 with FK 506 after experimental small intestine transplantation in the rat].
    Gasser M; Otto C; Timmermann W; Gassel HJ; Ulrichs K; Thiede A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):595-9. PubMed ID: 14518324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
    Kahan BD
    Transplantation; 2001 Jun; 71(11 Suppl):SS52-7. PubMed ID: 11583490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin.
    Siekierka JJ; Staruch MJ; Hung SH; Sigal NH
    J Immunol; 1989 Sep; 143(5):1580-3. PubMed ID: 2474605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.